GleamWall
中文EN

INCR Intercure Ltd. IFRS Annual reports only

Pharmaceutical Preparations · Nasdaq · SEC CIK 1857030 · Reporting currency ILS · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-32.8%
TTM net income YoY-9.4%
TTM EPS YoY-8.8%
Revenue 3-yr CAGR2.8%
Net income 3-yr CAGR—

Margins

Gross margin12.7%
Operating margin-28.1%
Net margin-28.4%
FCF margin-29.9%
EBITDA margin-21.7%

Returns

ROE-15.9%
ROA-8.8%
ROIC (approx.)-10.3%
Asset turnover0.31x

Leverage & solvency

Liabilities / assets47.9%
Debt / equity0.46x
Current ratio1.73x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.99x
Accruals ratio-0.1%
Payout ratio—
Capex / revenue1.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: ILS FY20242024-12-31FY20232023-12-31
Income statement
Revenue238.84M355.55M
Cost of revenue203.25M247.21M
Gross profit30.23M105.09M
R&D expense414,000388,000
SG&A expense53.67M42.61M
Operating income-67.21M-41.57M
Pretax income-87.32M-61.28M
Income tax-14.53M2.25M
Net income-67.80M-61.96M
EBITDA-51.84M-28.40M
EPS (basic)-1.48-1.36
EPS (diluted)-1.48-1.36
Balance sheet
Cash & equivalents78.32M101.14M
Short-term investments333,000187,000
Receivables51.85M60.41M
Inventory120.31M105.47M
Current assets391.80M418.80M
PP&E, netmay include right-of-use assets (IFRS)105.24M97.47M
Goodwill224.59M221.08M
Total assets762.57M786.61M
Current liabilities226.75M225.87M
Short-term debt69.44M88.19M
Long-term debt113.98M82.20M
Total debt183.41M170.40M
Total liabilities364.90M329.55M
Shareholders' equity396.97M455.11M
Net debt105.10M69.26M
Cash flow statement
Operating cash flow-66.93M-53.63M
Capital expenditure4.38M2.62M
Free cash flow-71.30M-56.25M
Investing cash flow17.69M4.77M
Financing cash flow26.45M-82.89M
Depreciation & amortization15.37M13.17M
Stock-based compensation2.28M2.59M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, ILS, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.